Placenta-specific protein 1 (PLAC1) expression regulated by TP53 in gynecologic cancer cell lines von McDonald, M.E, Miller, M, Warrier, A, Devor, E, Leslie, K.K, Gonzalez Bosquet, J

Volltext

Cluster analysis of chemotherapy non-responders for patients with serous epithelial ovarian cancer von McDonald, M.E, Salinas, E.A, Newtson, A.M, Goodheart, M.J, Leslie, K.K, Gonzalez Bosquet, J

Volltext

Stathmin over-expression correlates with poor prognosis in patients with endometrial cancer von Bosquet, J.G, Stephan, J.M, McDonald, M.E, Leslie, K.K

Volltext

Wnt signaling in human granulosa cell tumors of the ovary von Reyes, H.D, Kilonzo, B, Neff, T, Devor, E, Leslie, K.K, Samuelson, M, Cohen, E, Goodheart, M.J

Volltext

A clinical prediction model for chemoresponse in advanced-stage serous ovarian cancer von Newtson, A.M, Chung, R, McDonald, M.E, Salinas, E.A, Goodheart, M.J, Leslie, K.K, Devor, E, Gonzalez Bosquet, J

Volltext

Placenta-specific protein 1 (PLAC1) expression in serous ovarian cancer is significantly determined by p53 mutation status von Miller, M.D, Devor, E, Warrier, A, Reyes, H.D, Schickling, B.M, Goodheart, M.J, Leslie, K.K, Gonzalez Bosquet, J

Volltext

microRNA 31 is upregulated in serum during the window of implantation von Kresowik, J.D.K, Devor, E.J, Van Voorhis, B.J, Leslie, K.K

Volltext

Results of Gynecologic Oncology Group (GOG) 229 K: A phase II trial of BIBF-1120 for women with advanced, recurrent, or metastatic endometrial carcinoma von Sill, M, Schilder, J.M, McGonigle, K.F, Rahman, Z, Miller, D.S, Mutch, D.G, Leslie, K.K

Volltext

A phase II evaluation of cediranib in the treatment of recurrent or persistent endometrial cancer: An NRG Oncology/Gynecologic Oncology Group (GOG) study von Bender, D.P, Sill, M, Lankes, H, Darus, C.J, Delmore, J, Rotmensch, J, Gray, H.J, Mannel, R.S, Schilder, J.M, Leslie, K.K, Reyes, H.D, Hunter, M, McCourt, C.K, Samuelson, M

Volltext

HO-3867 rescues p53 repression of PLAC1 expression in ovarian cancer cells von Devor, E., Lapierre, J., Leslie, K.K.

Volltext

Population substructure may influence validation results of cancer genomics studies with TCGA datasets von Newtson, A.M., Miller, M.D., Devor, E., Salinas, E., Goodheart, M.J., Leslie, K.K., Gonzalez-Bosquet, J.

Volltext

Expression of Pleckstrin Homology and RUN Domain Containing M1 (PLEKHM1) is significantly associated with Grade and Prognosis in Endometrial Adenocarcinoma von Reyes, H.D., Devor, E., Newtson, A.M., Lyons, Y.A., McDonald, M., Wagner, V.M., Mattson, J.N., Leslie, K.K., Gonzalez-Bosquet, J.

Volltext

Hepatitis B and C in pregnancy: a review and recommendations for care von Dunkelberg, J C, Berkley, E M F, Thiel, K W, Leslie, K K

Volltext

Differential microRNA expression in endometrial cancer cells following exposure to aspirin von McDonald, M.E., Miller, M.D., Warrier, A., Leslie, K.K., Gonzalez-Bosquet, J., Devor, E.

Volltext

Selected genetic variation between endometrial endometrioid adenocarcinomas (EEA) and normal controls can be developed as minimally invasive screening markers for cancer developmen... von Reyes, H.D., Devor, E., Miller, M.D., Newtson, A.M., Lyons, Y.A., McDonald, M., Wagner, V.M., Mattson, J.N., Leslie, K.K., Bosquet, J. Gonzalez

Volltext

Evidence for synthetic lethality between bevacizumab and chemotherapy in advanced, p53 null endometrial cancers von Mallen, A.R., Filiaci, V.L., Levine, D.A., Thiel, K., Aghajanian, C.A., Meng, X., Devor, E., Moore, K.N., Powell, M.A., Secord, A.A., Tewari, K.S., Bender, D.P., Stuckey, A.R., Fowler, J.M., Dewdney, S.B., Leslie, K.K.

Volltext

Results of Gynecologic Oncology Group (GOG) 229K: A phase II trial of BIBF-1120 for women with advanced, recurrent, or metastatic endometrial carcinoma von Dizon, D.S., Sill, M., Schilder, J.M., McGonigle, K.F., Rahman, Z., Miller, D.S., Mutch, D.G., Leslie, K.K.

Volltext

Pregnancy specific β1 glycoprotein (SP-1) in maternal serum and amniotic fluid; Preeclampsia, small for gestational age fetus and fetal distress von Silver, R.M., Heyborne, K.D., Leslie, K.K.

Volltext

P53-Dependent Paclitaxel Sensitivity in Endometrial Cancer von Elmaoued, R., Holmes, A., Nguyen, T., Dai, D., Leslie, K.K.

Volltext

Tyrosine kinase inhibitors in endometrial cancer von Leslie, K.K., Laidler, L., Albitar, L., Davies, S., Holmes, A., Nguyen, T., Bolnick, J., Dai, D.

Volltext